Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population (Q48394651)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2003

Language	Label	Description	Also known as
English	Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population	scientific article published in January 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

1 reference

based on heuristic

inferred from title

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Olav Wendelboe Nielsen

object named as

Olav W Nielsen

1

0 references

author name string

Theresa A McDonagh

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

Stephen D Robb

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

Henry J Dargie

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

41

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

113-120

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical detection of left-ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma B-type natriuretic peptide measurement in a multiphasic health screening program

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902625-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(02)02625-6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12570953

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48394651&oldid=2196707251"